Determinants of COVID-19 Vaccination Intention among Health Care Workers in France: A Qualitative Study
Idioma
EN
Article de revue
Este ítem está publicado en
Vaccines. 2022-10-04, vol. 10, n° 10
Resumen en inglés
COVID-19 vaccines are one of the best tools to limit the spread of the virus. However, vaccine hesitancy is increasing worldwide, and France is one of the most hesitant countries. From the beginning of the COVID-19 vaccination ...Leer más >
COVID-19 vaccines are one of the best tools to limit the spread of the virus. However, vaccine hesitancy is increasing worldwide, and France is one of the most hesitant countries. From the beginning of the COVID-19 vaccination campaign, health care workers (HCW) have been prioritized in the vaccination strategy but were also hesitant. This study was conducted to identify and understand the determinants of COVID-19 vaccination intention in the French context, with a view to promoting HCW vaccination. A qualitative study using individual semi-structured interviews of HCWs was carried out at the beginning of the vaccination campaign (January to April 2021) in a French university hospital. Interviews indicated that the vaccination intention of HCWs was influenced by confidence in the proposed vaccines, past experience with vaccines and disease, the opinions and vaccination status of others, and media handling of information related to COVID-19 vaccination. Improving HCW vaccination intention regarding COVID-19 vaccines could be achieved through the dissemination of clear, reassuring, scientific information. Information should be disseminated by HCWs and vaccination experts and adapted to local contexts. To improve the level of confidence and vaccination uptake through a compliance effect, it would be useful to promote positive COVID-19 vaccination experiences and increased rates of immunization.< Leer menos
Palabras clave en inglés
COVID-19
Healthcare workers
Vaccine hesitancy
Vaccination intention
SARS-CoV-2
Qualitative study
Proyecto ANR
Etude des leviers permettant de maximiser la vaccination contre la Covid-19 dans la population adulte âgée de 18 à 64 ans à faible risque d'infection sévère - ANR-21-CO16-0006
Centros de investigación